These four groups were investigated:
(1) Unmodified EndoREZ (designated “Control”)
(2) EndoREZ + 1% MNPs (designated as “1% MNP”)
(3) EndoREZ + 2% MNPs (designated as “2% MNP”)
(4) EndoREZ + 2.5% DMADDM (designated as “2.5% DMADDM”)
(5) EndoREZ + 2.5% DMADDM + 1% MNPs (designated as “2.5% DMADDM + 1% MNP”)
(6) EndoREZ + 2.5% DMADDM + 2% MNPs (designated as “2.5% DMADDM + 1% MNP”)
The sealers were placed in cylindrical plastic molds (5 mm in diameter and 2.5 mm in height) for cytotoxicity and solubility tests. Resin flakes were made using a 48-well plate cover as a mold to test the antibacterial effect; 20 mg of each sealer was placed on the flakes as flatly as possible. All the samples were transferred into new 24-well plates in a humid environment at 37 °C for 7 days and sterilized using an ethylene oxide sterilizer.